CHMP recommends suspension of marketing approval for Ionsys
Janssen-Cilag recalled Ionsys in the European Union (EU) in September 2008, as a precautionary measure following identification of corrosion in a component of the system in one lot
The European Commission (EC) has approved Merck & Co’s (MSD) Keytruda (pembrolizumab) in combination with Padcev (enfortumab vedotin-ejfv) as a neoadjuvant treatment for muscle-invasive bladder cancer (MIBC).